SCHEMBL2163471

SCHEMBL2163471

CCCCCCCCC=CCCCCCCCC(=O)c1nnc(-c2ccccn2)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 10/20 1.00
CES1 P23141 7/20 1.00
NCEH1 Q6PIU2 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2163462 1.00 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL4835098 1.00 FAAH (1.00) FAAHCES1NCEH1
SCHEMBL4840954 0.85 FAAH (1.00) FAAHCES1
SCHEMBL4840946 0.85 FAAH (1.00) FAAHCES1
SCHEMBL14196696 0.85 FAAH (1.00) FAAHCES1
SCHEMBL3193600 0.83 FAAH (1.00) FAAHCES1
SCHEMBL3193554 0.80 FAAH (1.00) FAAHCES1
SCHEMBL3193561 0.80 FAAH (1.00) FAAHCES1
SCHEMBL4836309 0.80 CES1 (1.00) FAAHCES1NCEH1
SCHEMBL4831663 0.80 CES1 (1.00) FAAHCES1NCEH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096931-A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2008-04-24 US claimed
US-7351724-B2 Oxadiazole ketone inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2008-04-01 US claimed
EP-1812427-A1 OXADIAZOLE KETONE INHIBITORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2007-08-01 EP claimed
US-20060100212-A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2006-05-11 US claimed
WO-2006044617-A1 OXADIAZOLE KETONE INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2006-04-27 WO claimed
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-07-28 US disclosed
WO-2010005572-A2 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2010-01-14 WO disclosed
US-20080096931-A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2008-04-24 US disclosed
US-7351724-B2 Oxadiazole ketone inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2008-04-01 US disclosed
EP-1812427-A1 OXADIAZOLE KETONE INHIBITORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2007-08-01 EP disclosed
US-20060100212-A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2006-05-11 US disclosed
WO-2006044617-A1 OXADIAZOLE KETONE INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2006-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100212-A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase FAAH, FAAH2, HCRTR2 FAAH 1/4885CES1 60/4885NCEH1 22/4885
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS FAAH, FAAH2, FADS1 FAAH 1/4885CES1 11/4885NCEH1 17/4885
US-20080096931-A1 Oxadiazole ketone inhibitors of fatty acid amide hydrolase FAAH, FAAH2, HCRTR2 FAAH 1/4885CES1 60/4885NCEH1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.